Poststroke/CVA Paresis Clinical Trial
— iMoveOfficial title:
A Multicentre Randomized Single Blind Placebo Controlled Study to Assess Efficacy of Hand Exoskeleton Controlled by Motor Imagery Based BCI for Post Stroke Patients Movement Rehabilitation
| Verified date | September 2017 |
| Source | Russian Academy of Medical Sciences |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The purpose of this study is to assess the efficacy of non-invasive BCI-exoskeleton technology based on EEG patterns recognition matching to motor imagery in post-stroke patients with hand paresis.
| Status | Completed |
| Enrollment | 75 |
| Est. completion date | September 2017 |
| Est. primary completion date | September 2017 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years to 80 Years |
| Eligibility |
Inclusion Criteria: - Signed informed consent - Medical history of primary acute cerebrovascular event (ischemic or hemorrhagic stroke) at least 4 weeks before screening - focal stroke located in a hemisphere - post stroke hand paresis (mild to plegia according to Medical Research Council (MRC) Scale for Muscle Strength) Exclusion Criteria: - Montreal Cognitive Assessment (MoCA) scale < 22 - Left handedness - Sensory aphasia - Severe impairment of vision - Modified Ashworth Scale (MAS) = 4 |
| Country | Name | City | State |
|---|---|---|---|
| Russian Federation | Research Center of Neurology of RAMS | Moscow |
| Lead Sponsor | Collaborator |
|---|---|
| Russian Academy of Medical Sciences | Pirogov Russian National Research Medical University |
Russian Federation,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Change from Baseline in hand paresis level and hand muscle spasticity | ARAT; Fugl-Meyer, Modified Ashworth scale | Week 2 | |
| Secondary | Long-term changes from Baseline in hand paresis level and hand muscle spasticity | ARAT; Fugl-Meyer, Modified Ashworth scale | week 4, week 12, week 24 |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT01466296 -
The Middle East "Stepping Forward" Project (MESF)
|
Phase 2 |